ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990

In Brief: NCFA Offers Grants For Research On Impact Of DRGs; ACCC Leaders Dispute HCFA Chief

March 8, 1985

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008

Leukemia & Lymphoma Society offers translational research grants.

October 24, 2003

Centers Program Needs ‘Innovative Additions’ Such as SPORE Grants

September 20, 1991

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

November 25, 1977